Indegene Ltd

Nava Ltd, Saregama India Ltd, Aditya Birla Fashion & Retail Ltd, Ircon International Ltd are among the other stocks to see a surge in volumes on NSE today, 04 June 2025.Indegene Ltd witnessed volume of 375.17 lakh shares by 14:14 IST on NSE, a 156.99 times surge over two-week average daily volume of 2.39 lakh shares. The stock dropped 4.38% to Rs.592.55. Volumes stood at 8.77 lakh shares in the last session.Nava Ltd recorded volume of 119.22 lakh shares by 14:14 IST on NSE, a 29.79 times surge over two-week average daily volume of 4.00 lakh shares. The stock gained 9.24% to Rs.534.55. Volumes stood at 7.22 lakh shares in the last session.Saregama India Ltd witnessed volume of 55.5 lakh shares by 14:14 IST on NSE, a 25.69 times surge over two-week average daily volume of 2.16 lakh shares. The stock increased 4.43% to Rs.576.45. Volumes stood at 2.95 lakh shares in the last session.Aditya Birla Fashion & Retail Ltd registered volume of 2192.64 lakh shares by 14:14 IST on NSE, a 14.86 fold spurt over two-week average daily volume of 147.54 lakh shares. The stock slipped 10.30% to Rs.77.14. Volumes stood at 34.52 lakh shares in the last session.Ircon International Ltd clocked volume of 673.94 lakh shares by 14:14 IST on NSE, a 9.04 times surge over two-week average daily volume of 74.53 lakh shares. The stock gained 12.71% to Rs.218.59. Volumes stood at 70.42 lakh shares in the last session.Powered by Capital Market - Live

Indegene announced that the 27th Annual General Meeting(AGM) of the company will be held on 26 June 2025.Powered by Capital Market - Live

Indegene announced that the Board of Directors of the Company at its meeting held on 28 April 2025, inter alia, have recommended the final dividend of Rs 2 per equity Share (i.e. 100%) , subject to the approval of the shareholders.Powered by Capital Market - Live

Net profit of Indegene rose 24.05% to Rs 117.60 crore in the quarter ended March 2025 as against Rs 94.80 crore during the previous quarter ended March 2024. Sales rose 12.27% to Rs 755.60 crore in the quarter ended March 2025 as against Rs 673.00 crore during the previous quarter ended March 2024. For the full year,net profit rose 20.79% to Rs 406.70 crore in the year ended March 2025 as against Rs 336.70 crore during the previous year ended March 2024. Sales rose 9.64% to Rs 2839.30 crore in the year ended March 2025 as against Rs 2589.60 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales755.60673.00 12 2839.302589.60 10 OPM %19.5220.61 -18.8219.52 - PBDT170.00149.60 14 619.50532.30 16 PBT149.30131.10 14 539.30456.20 18 NP117.6094.80 24 406.70336.70 21 Powered by Capital Market - Live

Indegene will hold a meeting of the Board of Directors of the Company on 28 April 2025.Powered by Capital Market - Live

Indegene, a digital-first life sciences commercialization company, today announced the launch of a new center in London. This aligns with the company's long-term growth strategy in Europe, reiterating its commitment to enable life sciences clients in the region to be future-ready. Indegene's Europe-based clients can now benefit from this center as a strategic hub for consulting and commercialization solutions and modernize their operations with an AI-first approach. The company is strengthening its existing employee base in the region, with skillsets spanning a wide range of areas - consulting, creative, data and analytics, engineering and customer experience. 'London is a vital healthcare, technology and business innovation hub, with a great talent pool - making it an important market for life sciences companies in the region', said Manish Gupta, Chairman and CEO, Indegene. 'With our new center, we are better positioned to dial up innovation and engagement with our clients here and help them holistically improve their commercialization processes with an AI-first approach and stay ahead of the curve.'Powered by Capital Market - Live

Indegene has been recognized as one of the standout winners of Deloitte Private's Enterprise Growth Awards 2025. The awards acknowledged Indegene's commitment to its purpose of enabling healthcare organizations to be future-ready, its robust corporate governance practices and sustained growth. Enterprise Growth Awards is a unique programme by Deloitte Private dedicated to celebrating businesses that have transformed local ambitions into national and global success stories. These awards showcase inspiring stories of businesses that have built lasting legacies while maintaining sustainable growth trajectories and aim to inspire the next generation of entrepreneurs. Powered by Capital Market - Live

Indegene has been recognized as one of the standout winners of Deloitte Private's Enterprise Growth Awards 2025. The awards acknowledged Indegene's commitment to its purpose of enabling healthcare organizations to be future-ready, its robust corporate governance practices and sustained growth. Enterprise Growth Awards is a unique programme by Deloitte Private dedicated to celebrating businesses that have transformed local ambitions into national and global success stories. These awards showcase inspiring stories of businesses that have built lasting legacies while maintaining sustainable growth trajectories and aim to inspire the next generation of entrepreneurs. Powered by Capital Market - Live

Indegene launched Cortex, a fit-for-purpose Generative AI (GenAI) platform, verticalized for the life sciences industry. As a life sciences-specialist knowledge engineering and multiagent orchestration platform, Cortex by Indegene enables life sciences leaders to adopt and scale this transformative technology with enterprise-grade governance. This innovative platform is strategically essential to developing and scaling high-value life sciences use cases such as streamlining the content supply chain, making medical writing more effective and efficient, and accelerating Medical-Legal-Regulatory (MLR) reviews. Its knowledge engineering interface codifies Indegene's 25+ years of subject matter expertise into advanced knowledge graphs using a domainfriendly interface. Moreover, its fit-for-purpose agents can be configured with any preferred Large Language Model (LLM) and evolve as LLM state-of-the-art improves. Further, its multi-agent orchestration enables use case-specific applications for enterprise-wide system integration. Together, these yield more reliable, accurate and trustworthy outcomes from LLM-based agents with substantially faster turnaround times and better ROI at lower risk, relative to industry-agnostic platforms. This GenAI platform's embedded domain knowledge graphs capture nuances and details of life sciences' processes and tasks and benefit from continuous improvement.  Powered by Capital Market - Live

Indegene announced the launch of a new entity in Spain. This move marks a key step in the company's ongoing strategic expansion in Europe and aligns with Indegene's commitment to helping life sciences companies accelerate AI-driven innovation and make their operations future-ready. Indegene's new Spain entity will serve as a key delivery hub for its Europe-based clients, helping them drive hyper-personalization and significantly elevate HCP and patient experience. The company is strengthening its already existing employee base in Spain, with capabilities in medical affairs, data and analytics, creative design, engineering, digital marketing and customer experience. Indegene already has a significant presence in Europe, with centers in the UK, Germany, Ireland and Switzerland. Last year, Indegene acquired Trilogy Writing & Consulting GmbH (Trilogy), a global provider of specialty medical writing capabilities across clinical, regulatory, safety and medical content to life sciences companies. In 2019, Indegene acquired DT Associates (now DT Consulting), a consulting services company in the UK that supports clients in the healthcare and life sciences space. Indegene supports many leading life sciences clients in the region in various ways across the commercialization value chain. Powered by Capital Market - Live